Myokardia Inc (NASDAQ: MYOK) shares jumped 74.1 percent to $29.86. MyoKardia posted a Q2 loss of $0.41 per share on sales of $5.63 million. The company also reported 'positive' topline results in Phase 2 PIONEER-HCM study.
Midway through trading Monday, the Dow traded up 0.01 percent to 22,093.28 while the NASDAQ climbed 0.25 percent to 6,367.70. The S&P also rose, gaining 0.02 percent to 2,477.19.
Leading and Lagging Sectors
On Monday, the basic materials...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to NxStage Medical (NXTM):